Poland - Zamość: Pharmaceutical products

Release

ID: ocds-pyfy63:2023-219034:2023-508616
Buyer: Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu
Date: 2023-08-23
Language: PL
Tags: award

Release in JSON

Process

ID (OCID): ocds-pyfy63:2023-219034
Releases: 2023-04-12 (ocds-pyfy63:2023-219034:2023-219034)
2023-05-12 (ocds-pyfy63:2023-219034:2023-282106)
2023-08-23 (ocds-pyfy63:2023-219034:2023-508616)

Releases in JSON

Tender

Title: Poland - Zamość: Pharmaceutical products
Award criteria: priceOnly
Award criteria details: Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price
Main procurement category: goods
Procurement method: open
Procurement method details: Open procedure
Tender period: 2023-08-23 - ?
Tenderers: Komtur Polska Sp. z o.o.
Urtica Sp. z o.o.
Asclepios SA
Roche Polska Sp. z o.o.
AstraZeneca Kft.
Fresenius Kabi Polska Sp. z o.o.
Bialmed Sp. z o.o.
Amgen Sp. z o.o.
Astellas Pharma Sp. z o.o.
Farmacol Logistyka Sp. z o.o.
GSK Services Sp. z o.o.
Janssen – Cilag Polska Sp. z o.o.
Centrala Farmaceutyczna Cefarm SA
Abbvie Sp. z o.o.

Tender item

ID: ocds-pyfy63:2023-219034:obj:1
Classification: CPV / 33600000
Description: Nab- paklitaksel - 330 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:2
Classification: CPV / 33600000
Description: Palbocyklib - 30 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:3
Classification: CPV / 33600000
Description: 1. Irinotecan - 400 op.2. Irinotecan - 600 op.3. Irinotecan - 500 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:4
Classification: CPV / 33600000
Description: Trastuzumab emtanzyna - 250 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:5
Classification: CPV / 33600000
Description: Rybocyklib - 60 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:6
Classification: CPV / 33600000
Description: Olaparib - 89 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:7
Classification: CPV / 33600000
Description: Vinorelbina - 1600 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:8
Classification: CPV / 33600000
Description: 1. Oxaliplatina - 200 op.2. Oxaliplatina - 840 op.3. Oxaliplatina - 500 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:9
Classification: CPV / 33600000
Description: 1. Paclitaxel - 600 op.2. Paclitaxel - 500 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:10
Classification: CPV / 33600000
Description: Pemetrexed - 450 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:11
Classification: CPV / 33600000
Description: 1. Rituximab - 10 op.2. Rituximab - 20 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:12
Classification: CPV / 33600000
Description: Atezolizumab - 200 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:13
Classification: CPV / 33600000
Description: Topotecan - 100 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:14
Classification: CPV / 33600000
Description: 1. Trastuzumab - 150 op.2. Trastuzumab - 360 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:15
Classification: CPV / 33600000
Description: 1. Trastuzumab - 150 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:16
Classification: CPV / 33600000
Description: Lapatynib - 15 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:17
Classification: CPV / 33600000
Description: 1. Panitumumab - 45 op.2. Panitumumab - 45 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:18
Classification: CPV / 33600000
Description: 1. Pazopanib - 45 op.2. Pazopanib - 5 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:19
Classification: CPV / 33600000
Description: Denosumab - 90 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:20
Classification: CPV / 33600000
Description: Enzalutamid - 140 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:21
Classification: CPV / 33600000
Description: Infliximab - 400 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:22
Classification: CPV / 33600000
Description: Abirateron - 65 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:23
Classification: CPV / 33600000
Description: Niraparib - 20 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:24
Classification: CPV / 33600000
Description: Wedolizumab - 50 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:25
Classification: CPV / 33600000
Description: Dabrafenib - 15 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:26
Classification: CPV / 33600000
Description: Trametinib - 15 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:27
Classification: CPV / 33600000
Description: Sacituzumab govitecan - 288 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:28
Classification: CPV / 33600000
Description: Ondansetron - 2250 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:29
Classification: CPV / 33600000
Description: Pegfilgrastim - 550 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:30
Classification: CPV / 33600000
Description: Ipilimumab - 60 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:31
Classification: CPV / 33600000
Description: Octan glatirameru - 187 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:32
Classification: CPV / 33600000
Description: Avelumab - 52 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:33
Classification: CPV / 33600000
Description: Apalutamid - 12 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:34
Classification: CPV / 33600000
Description: Pembrolizumab - 330 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:35
Classification: CPV / 33600000
Description: Ofatumumab - 450 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:36
Classification: CPV / 33600000
Description: 1. Siponimod - 25 op.2. Siponimod - 36op.3. Siponimod - 260 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:37
Classification: CPV / 33600000
Description: 1. Cladribine - 2 op.2. Cladribine - 2 op.3. Cladribine - 2 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:38
Classification: CPV / 33600000
Description: 1. Ozanimod - 5 op.2. Ozanimod - 39 op.

Tender item

ID: ocds-pyfy63:2023-219034:obj:39
Classification: CPV / 33600000
Description: Lewodopa + karbidopa - 48 op.

Award

ID: ocds-pyfy63:2023-219034:award:0
Title: 1
Date: 2023-06-27
Status: active
Suppliers: Komtur Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:1
Title: 2
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:2
Title: 3
Date: 2023-06-27
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2023-219034:award:3
Title: 4
Date: 2023-06-27
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:4
Title: 5
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:5
Title: 6
Date: 2023-06-27
Status: active
Suppliers: AstraZeneca Kft.

Award

ID: ocds-pyfy63:2023-219034:award:6
Title: 7
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:7
Title: 8
Date: 2023-06-27
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2023-219034:award:8
Title: 9
Date: 2023-06-27
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:9
Title: 10
Date: 2023-06-27
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:10
Title: 11
Date: 2023-06-27
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2023-219034:award:11
Title: 12
Date: 2023-06-27
Status: active
Suppliers: Roche Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:12
Title: 13
Date: 2023-06-27
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:13
Title: 14
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:14
Title: 15
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:15
Title: 16
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:16
Title: 17
Date: 2023-06-27
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:17
Title: 18
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:18
Title: 20
Date: 2023-06-27
Status: active
Suppliers: Amgen Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:19
Title: 20
Date: 2023-06-27
Status: active
Suppliers: Astellas Pharma Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:20
Title: 21
Date: 2023-06-27
Status: active
Suppliers: Bialmed Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:21
Title: 22
Date: 2023-06-27
Status: active
Suppliers: Farmacol Logistyka Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:22
Title: 23
Date: 2023-06-27
Status: active
Suppliers: GSK Services Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:23
Title: 24
Status: unsuccessful

Award

ID: ocds-pyfy63:2023-219034:award:24
Title: 25
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:25
Title: 26
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:26
Title: 27
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:27
Title: 28
Date: 2023-06-27
Status: active
Suppliers: Fresenius Kabi Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:28
Title: 29
Date: 2023-06-27
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2023-219034:award:29
Title: 30
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:30
Title: 31
Date: 2023-06-27
Status: active
Suppliers: Asclepios SA

Award

ID: ocds-pyfy63:2023-219034:award:31
Title: 32
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:32
Title: 33
Date: 2023-06-27
Status: active
Suppliers: Janssen – Cilag Polska Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:33
Title: 34
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:34
Title: 35
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:35
Title: 36
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:36
Title: 37
Date: 2023-06-27
Status: active
Suppliers: Centrala Farmaceutyczna Cefarm SA

Award

ID: ocds-pyfy63:2023-219034:award:37
Title: 38
Date: 2023-06-27
Status: active
Suppliers: Urtica Sp. z o.o.

Award

ID: ocds-pyfy63:2023-219034:award:38
Title: 39
Date: 2023-06-27
Status: active
Suppliers: Abbvie Sp. z o.o.

Parties

Roles: buyer
Organization name: Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu
Street address: ul. Aleje Jana Pawła II 10
Locality: Zamość
Postal code: 22-400
Country: PL
Contact name: Agata Bosiak
E-mail: zamowienia@szpital.zam.pl
Phone: +48 846773329
Fax: +48 846386669
Website: Link